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whose structure both depends on growth
factor identity and correlates with
downstream signaling. Alternative coiled
coils communicate chemical information
across the plasma membrane.
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Binding of transforming growth factor a (TGF-a) to
the epidermal growth factor receptor (EGFR) extra-
cellular domain is encoded through the formation of
a unique antiparallel coiled coil within the juxtamem-
brane segment. This new coiled coil is an ‘‘inside-
out’’ version of the coiled coil formed in the presence
of epidermal growth factor (EGF). A third, interme-
diary coiled-coil interface is formed in the juxta-
membrane region when EGFR is stimulated with
betacellulin. The seven growth factors that activate
EGFR in mammalian systems (EGF, TGF-a, epigen,
epiregulin, betacellulin, heparin-binding EGF, and
amphiregulin) fall into distinct categories in which
the structure of the coiled coil induced within the
juxtamembrane region correlates with cell state.
The observation that coiled-coil state tracks with
the downstream signaling profiles for each ligand
provides evidence for growth factor functional selec-
tivity by EGFR. Encoding growth factor identity in
alternative coiled-coil rotamers provides a simple
and elegant method for communicating chemical
information across the plasma membrane.
INTRODUCTION
There remains an incomplete understanding of how the
epidermal growth factor receptor (EGFR), the prototypic mem-
ber of the receptor tyrosine kinase superfamily, communicates
ligand identity across the plasma membrane. Despite multiple
high-resolution views of the extracellular ligand binding (Fergu-
son et al., 2003; Garrett et al., 2002; Ogiso et al., 2002) and intra-
cellular kinase (Jura et al., 2009; Zhang et al., 2006) domains and
a rudimentary understanding of the basic activation mechanism
(Arkhipov et al., 2013; Endres et al., 2013; Lu et al., 2010), how
this information is decoded into ligand-dependent differences
in cell state remains unclear (Wilson et al., 2009). In previous
work, we made use of bipartite tetracysteine display (Luedtke
et al., 2007) and the bis-arsenical dye ReAsH (Adams et al.,
2002) to probe how ligand binding to the EGFR extracellular
domain influences structure within the cytoplasmic juxtamem-776 Chemistry & Biology 22, 776–784, June 18, 2015 ª2015 Elsevierbrane segment (JM) (Figure 1A). The JM is a short (37 amino
acids) sequence that links the extracellular ligand binding and
transmembrane domains to the intracellular kinase domain and
stabilizes the receptor active state (Jura et al., 2009). We discov-
ered that binding of the epidermal growth factor (EGF) to the
EGFR extracellular domain induced the formation of a discrete
antiparallel coiled coil (Jura et al., 2009) within the juxtamem-
brane-A (JM-A) segment, whereas binding of the alternative
growth factor, transforming growth factor a (TGF-a), induced
an alternative, helical interface whose structure was not estab-
lished (Figure 1A) (Scheck et al., 2012). As predicted by nuclear
Overhauser effects seen in short peptide models (Jura et al.,
2009), the EGF-induced antiparallel structure is characterized
by leucine residues at the a and d positions of the paired heptad
repeat and complementary electrostatic interactions at positions
e and g (Figure S1B). Here, we provide evidence that the helical
interface formed in the presence of TGF-a is an ‘‘inside-out’’
version of the EGF-induced structure, in which paired polar
interactions predominate at the antiparallel interface (Fig-
ure S1C). We show further that the seven growth factors that
activate EGFR in mammalian systems—EGF, TGF-a, epigen
(EPI), epiregulin (ER), betacellulin (BC), heparin-binding EGF
(HB), and amphiregulin (AR)—fall into distinct categories in which
the structure of the coiled coil induced within the JM correlates
directly with cell state.
In our prior work, we designed three Cys-Cys EGFR variants
(CCH-1, -2, and -3) (Figures 1B and S1A) that reported on the for-
mation of the EGF-induced antiparallel coiled coil in live cells
(Scheck et al., 2012). When this structure forms within a receptor
dimer, the assembled tetracysteine motif is poised to bind
ReAsH and cause it to fluoresce. Expression of CCH-1, -2,
or -3 on theCHO-K1 cell surface resulted in a significant increase
in normalized ReAsH fluorescence in the presence of EGF but
not TGF-a. In contrast, expression of the EGFR variants CCH-5
andCCH-6 resulted in a significant increase in normalized ReAsH
fluorescence in the presence of TGF-a but not EGF (Scheck
et al., 2012). Given the spatial requirements for ReAsH binding
(Goodman et al., 2009), these observations led to the conclusion
EGFR communicates ligand identity to the cytosol through at
least two, discrete, helical JM-A conformations. Here, we apply
both computation and experimentation to demonstrate that the
helical interface formed in the presence of TGF-a is best charac-
terized as an ‘‘inside-out’’ version of the interface formed in the
presence of EGF; the two antiparallel coiled coils are related
by a 150 disrotatory rotation about each helix axis. We alsoLtd All rights reserved
Figure 1. Probing Juxtamembrane Segment Structure within Full-
Length EGFR on the Cell Surface Using Bipartite Tetracysteine
Display and TIRF Microscopy
(A) EGF and TGF-a induce different structures within the EGFR juxtamem-
brane segment (JM) (Luedtke et al., 2007; Scheck et al., 2012; Scheck and
Schepartz, 2011).
(B) Helical wheel diagrams of five EGFR variants used previously to distinguish
antiparallel coiled-coil arrangements. For sequences, see Figure S1A. In
CCH-6, the Cys-Cys motifs are separated axially by a helical turn and do not
assemble an ReAsH binding site (see also Figure S1). Figure 2. RosettaDock Analysis of the EGFR Juxtamembrane
Segment Conformational Landscape
(A) Procedure used to generate and evaluate potential paired helix interactions
of the EGFR JM.
(B) Low-energy structures identified by RosettaDock (Gray et al., 2003) ranked
in order of increasing Rosetta score and separated by strand orientation.
Clusters representing possible EGF-, TGF-a-, and BC-type structures are
shown in orange, yellow, and pink, respectively. For the relative Rosetta rank of
all clusters, see also Figure S2.identify a third, intermediary interface formed when EGFR is
stimulated with betacellulin. We show further that the seven
growth factors that activate EGFR in mammalian systems
(EGF, TGF-a, EPI, ER, BC, HB, and AR) fall into distinct cate-
gories in which the structure of the antiparallel coiled coil
induced within the juxtamembrane segment correlates with
downstream signaling outcomes. The observation that the
coiled-coil state tracks with the downstream signaling profile
for each ligand provides evidence for growth factor functional
selectivity by EGFR. Encoding growth factor identity in alterna-
tive coiled-coil rotamers provides a simple and elegant method
for communicating chemical information across the plasma
membrane.
RESULTS
Evaluating the Diversity of the JM Helical Landscape In
Silico
We first sought to identify the structure of the JM-A helical inter-
face formed when EGFR is stimulated with TGF-a. Preliminary
disulfide exchange and circular dichroism spectroscopy experi-
ments revealed that peptides containing the minimal JM-A
segment (residues 650–666) do not appreciably form dimers at
concentrations below 150 mM (Scheck et al., 2012; SinclairChemistry & Biology 22,et al., 2014), precluding a straightforward biophysical analysis
of the isolated peptides. Thus, we turned to an in silico analysis
to explore the diversity of the JM-A conformational landscape in
the absence of complicating oligomerization events, and then
used bipartite tetracysteine display to detect these diverse con-
formations in the context of the intact receptor.
We used RosettaDock (Gray et al., 2003) to analyze thousands
of potential dimeric JM-A helical interactions in silico. The inter-
acting JM-A helices (residues 650–666) were oriented randomly,
docked as rigid bodies, and the complexes subject to an all-
atom minimization to optimize side-chain conformations (Fig-
ure 2A). We generated 25,000 output structures, and the top-
scoring 1,000 were clustered on the basis of root-mean-square
deviation (RMSD) differences. The 60 lowest-energy clusters—
320 structures, roughly 1.3% of the total search space—were
filtered to identify 15 clusters possessing the symmetric interface
(homodimeric) that is prerequisite for ReAsH binding.776–784, June 18, 2015 ª2015 Elsevier Ltd All rights reserved 777
The 15 homodimeric clusters (Figure 2B) were highly diverse.
As expected, the antiparallel structure for EGF-activated EGFR
that was proposed by Jura et al. (2009) and confirmed by bipar-
tite display (Scheck et al., 2012) and nuclearmagnetic resonance
(Endres et al., 2013; Jura et al., 2009) defined one low-energy
cluster (antiparallel cluster 5) (Figure 2B and Figure S4D). How-
ever, the set of lowest-energy homodimeric clusters also con-
tained many other structures whose helices were either parallel
(36%) or antiparallel with significant deviation from cluster 5
(64%). The diversity of structures within an isolated but dimeric
JM-A region predicted by RosettaDock is consistent with the
short length (14 amino acids) of the interacting JM-A helices,
which lack the compounding and biasing interactions provided
by the intact, dimeric, receptor in complex with a specific acti-
vating growth factor. We turned to bipartite tetracysteine display
to differentiate between these predicted models for full-length
EGFR on the cell surface.
Evaluation of Clusters Containing Parallel Helices
We noticed that one cluster containing parallel homodimeric
helices exhibited a favorable Rosetta rank (parallel cluster 57).
Closer examination indicated that the structures in this cluster
(Figures S3A and S3B) possessed a leucine-rich helical interface
much like the EGF-induced antiparallel coil (Jura et al., 2009)
observed in cells (Scheck et al., 2012). This parallel structure
would have assembled a favorable tetracysteine binding site
for ReAsH within the JM-A of the CCH-1 EGFR dimer, as the
Cys-Cys motif in each monomer lies near the center of the
JM-A sequence (Figures S1A and S3C). As a result, CCH-1 alone
cannot distinguish between themore frequently considered anti-
parallel structures in cluster 5 or the parallel structures found in
cluster 57. Although the Cys-Cys motifs in CCH-2 and CCH-3
form non-ideal ReAsH binding sites when assembled into the
structures found in cluster 57, this cluster could not be ruled
out without additional experimentation, as only a slight helical
rotation would be required to create an ideal ReAsH binding
site. Thus, we sought to determine whether the parallel helical
structures in cluster 57 are populated when full-length EGFR is
activated with EGF on the surface of live cells.
To identify the cluster-57 structures and distinguish them from
the antiparallel structures in cluster 5, we designed a new EGFR
variant suitable for bipartite tetracysteine display, CCH-7. This
variant carries a Cys-Cys motif at the N terminus of the JM-A
sequence to ensure formation of a competent ReAsH binding
site only if the parallel helical array in cluster 57 were to form
(Figures S3E and S3F). Although CCH-7 expressed in CHO-K1
cells is active upon treatment with EGF (Figures S3G and S3H),
ReAsH treatment did not result in a significant increase in fluo-
rescence above background (Figures S3I and S3J). The same
result was observed when cells expressing CCH-7 were treated
with TGF-a. These observations failed to provide evidence for
formation of the parallel coiled coil in cluster 57 when EGFR
was activated with EGF (Scheck et al., 2012).
Having validated the utility of RosettaDock to refine our under-
standing of the EGF-induced structure within the EGFR JM-A
dimer, we next sought to identify themost likely structure formed
when EGFR is instead activated by TGF-a. We turned first to one
set of related, parallel coiled coils (parallel cluster 53, Figures
S3A and S3B) that would support ReAsH binding by the two778 Chemistry & Biology 22, 776–784, June 18, 2015 ª2015 Elsevierpreviously reported EGFR variants CCH-5 and CCH-6 (Figures
1B and S3D), and thus could represent the alternative TGF-
a-induced conformation(s). To test for this parallel structure
using bipartite tetracysteine display, we designed EGFR variant
CCH-8, using the same strategy used to design CCH-7, with
cysteine residues at the C terminus of the helical interaction (Fig-
ures S3E and S3F). As was found for experiments employing
CCH-7, while CCH-8 expressed in CHO-K1 cells is active upon
treatment with TGF-a (Figures S3G and S3H), treatment with
ReAsH led to no significant increase in fluorescence above back-
ground (Figures S3I and S3J). Taken together, the in silico and
bipartite display experiments suggest that neither EGF nor
TGF-a induce the formation of a parallel helical interface within
activated EGFR.
Evaluation of Clusters Containing Antiparallel Helices
Having ruled out the parallel structure clusters, we next consid-
ered the large number of low-energy antiparallel structure clus-
ters identified by RosettaDock to determine whether any could
be populated when EGFR is activated with TGF-a. We focused
on two clusters whose antiparallel structures were both low en-
ergy andcompatiblewith thepreviously observedReAsHbinding
to EGFR variants CCH-5 and/or CCH-6 upon TGF-a activation
(Figures 1B and S1A): clusters 1 and 49 (Figures 2B, 3A, and
S4D) (Scheck et al., 2012). Antiparallel cluster 1 contains lower-
energy structures, but the structures in antiparallel cluster 49
form better ReAsH binding sites with the CCH-5 and CCH-6
Cys-Cysmotifs (FigureS4A).We thus turned tobipartite tetracys-
teine display to differentiate between these models for TGF-a-
activated EGFR expressed on the mammalian cell surface.
Differentiating between the structures in clusters 1 and 49 us-
ing ReAsH and bipartite tetracysteine display required careful
design. This design recognizes that ReAsH binding sites on anti-
parallel coiled coils fall into three categories (Figure 4). Antipar-
allel arrays with Cys-Cys motifs at positions a and d, g and d,
or a and ewithin a single heptad repeat (shown in green) support
robust ReAsH binding and fluorescence, whereas those with
Cys-Cys motifs at positions f and c and f and b (shown in red)
do not. More context dependent are sites in the third category,
antiparallel arrays carrying Cys-Cys motifs at positions b and e
or c and g (shown in gray): these structures could support ReAsH
binding and fluorescence in the context of a flexible JM struc-
ture. With these guidelines, we designed CCH-9 to differentiate
between the structures in clusters 1 and 49 (Figure 3B). In this
EGFR variant, the Cys-Cys motif occupies the favorable g and
d (and g0 and d0) positions if the helices are arranged as pre-
scribed by cluster 1, and the unfavorable f and c (and f0 and c0)
positions if the helices are arranged as prescribed by cluster
49 (Figure S4B). Thus, TGF-a-treated cells expressing CCH-9
should fluoresce after ReAsH treatment if a cluster-1 coiled
coil is formedwithin the EGFR JM-A, but not if a cluster-49 coiled
coil has formed.
Evidence that the TGF-a-Induced Coiled Coil Is
Inside-Out
Examination of cells transfected with CCH-9 (Figure 3C) revealed
that addition of TGF-a led to a greater than 2-fold increase in
ReAsH fluorescence in comparison with untreated CCH-9-ex-
pressing cells, favoring cluster 1 as the JM-A structure formedLtd All rights reserved
Figure 3. TGF-a Induces an ‘‘Inside-Out’’ Helical Interaction in the
JM-A
(A) Helical wheel diagrams illustrating two antiparallel interfaces potentially
adopted in the presence of TGF-a.
(B) JM-A regions of CCH-9 and CCH-10.
(C and E) TIRF images of CHO-K1 cells expressing either FLAG-tagged CCH-9
or CCH-10 (green fluorescence) and treated with EGF or TGF-a (1 ng/ml) and
ReAsH. Scale bars represent 10 mm.
(D and F) Quantified fold increase in expression-corrected ReAsH fluores-
cence over background of cells expressing CCH-9 or CCH-10 and treated with
or without EGF or TGF-a. We attribute the slightly lower ReAsH fluorescence of
CCH-10 to the lower activity of this mutant (see also Figure S4E). Error bars
represent SE. ****p < 0.0001 from one-way ANOVA with Bonferroni post-test
(see also Figure S4).in the presence of TGF-a and ruling out cluster 49 (Figure 3D).
Nevertheless, we observed that cells transfected with CCH-9
also exhibited a 1.5-fold increase in ReAsH fluorescence in the
presence of EGF, presumably because when the EGF-type
coiled coil is formed (cluster 5), the Cys-Cys motif in CCH-9 oc-
cupies the ambiguous b and e positions (Figure S4B). As we
desired an EGFR variant that would bind ReAsH and fluoresce
only when activated with TGF-a, we next designed CCH-10 (Fig-
ure 3B). Here, the Cys-Cys motif occupies the favorable a and
d (and a0 and d0) positions if the helices are arranged as pre-
scribed by cluster 1 (induced by TGF-a) and the unfavorable b
and f (and b0 and f0) positions if the helices are arranged as pre-
scribed by cluster 5 (induced by EGF) (Figure S4C). As a result,
we would expect that cells expressing CCH-10 should fluoresceChemistry & Biology 22,after ReAsH treatment when a cluster-1 structure is present, but
not when a cluster-5 coiled coil has formed; therefore, these cells
should fluoresce only in the presence of TGF-a. Western blot
analysis of cells transfected with CCH-10, WT EGFR and
CCH-1 showed similar patterns of C-terminal phosphorylation
(Figures S4E and S4F); total internal reflection fluorescence
(TIRF) microscopy (Figure 3E) revealed that addition of TGF-a
to cells transfected with CCH-10 led to a 1.5-fold increase in
ReAsH fluorescence, whereas addition of EGF had no effect
(Figure 3F). Taken together, the observation of robust ReAsH
fluorescence when cells expressing either CCH-9 or CCH-10
are treated with TGF-a provides compelling evidence that the
antiparallel helical structures in cluster 1 best represent the JM
when EGFR is activated by TGF-a. Moreover, the EGFR variant
CCH-10 can specifically detect this conformation and distinguish
it from the EGF-activated state embodied by cluster 5.
Coiled-Coil Structure Correlates with Effect on
Cell State
Seven growth factors activate EGFR, five in addition to EGF and
TGF-a: EPI, ER, BC, AB, and AR. Numerous studies have shown
that these seven growth factors segregate into two categories
when their effects on downstream signaling are compared: acti-
vation with EGF, HB, or BC leads to greater receptor down-regu-
lation and a shorter signaling pulse, whereas activation with
TGF-a, AR, ER, or EPI promote receptor recycling and sustained
signaling that increases cell proliferation (Baldys et al., 2009;
Ebner and Derynck, 1991; Reddy et al., 1998; Roepstorff et al.,
2009; Seth et al., 1999; Thoresen et al., 1998; Wilson et al.,
2012). As ligand identity must be translated through the receptor
to intracellular signaling proteins, we sought to determine, using
CCH-1 and CCH-10, whether these signaling differences corre-
lated with JM-A conformation. To evaluate the presence of the
EGF-type coiled coil (represented by cluster 5) or the TGF-
a-type coiled coil (represented by cluster 1), we treated cells ex-
pressing the EGFR variants CCH-1 or CCH-10 with saturating
concentrations (as determined by western blot, see Figures
S5A and S5H) of AR, BC, ER, EPI, and HB, andmonitored ReAsH
fluorescence (Figures 5A and S5B). Examination of cells trans-
fected with CCH-1 revealed a 2-fold increase in ReAsH fluores-
cence upon addition of BC, HB, and EGF, but not upon addition
of TGF-a, AR, ER, or EPI. By contrast, cells transfected with
CCH-10 displayed a 1.5-fold increase in ReAsH fluorescence
upon addition of TGF-a, AR, and ER and a 1.3-fold increase for
BC and EPI, but no increase in ReAsH fluorescence was
observed upon addition of HB and EGF (Figure 5A). We attribute
the lower fold increase upon EPI treatment to lower ligand po-
tency, as detected by EGFR autophosphorylation (Figures S5A
and S5H). Thus, with the exception of BC (vide infra), there is a
direct correlation between the effect of a growth factor on
JM-A structure and the temporal dynamics of the overall
signaling response.
A Third JM Conformation Is Formed upon BC Activation
Among the growth factors that activate EGFR, BC is unique in its
ability to elicit robust ReAsH fluorescence from cells expressing
either CCH-1 or CCH-10 (Figure 5A). This observation suggests
that BC either induces both the TGF-a- and EGF-type coiled
coils, presumably due to a significant increase in flexibility, or776–784, June 18, 2015 ª2015 Elsevier Ltd All rights reserved 779
Figure 4. Categorization of Three Types of
Cys-Cys ReAsH Binding Sites Formed by
Dimeric Coiled Coils as Defined by Cysteine
Proximitythat it induces a third, intermediary conformation that is compat-
ible with ReAsH binding by both CCH-1 and CCH-10. To distin-
guish these possibilities, we returned to the top-scoring struc-
ture clusters predicted by RosettaDock (Figure 2B). Because
BC activation led to robust ReAsH fluorescence in both CCH-1
and CCH-10-expressing cells, we looked to identify structures
that positioned the Cys-Cys motifs in both CCH-1 and CCH-10
such that ReAsH fluorescence could be observed using either
variant (Figure 4). This strategy identified three possible models:
those in clusters 12, 55, and 49 (Figures 5B and S5E) (see Fig-
ure S5C for Cys-Cys motif placements in each model).
To differentiate between these threemodels, we turned to pre-
viously designed EGFR variants. First, we predicted that CCH-9
should provide a robust ReAsH binding site if the JM-A were to
assemble into structures in cluster 12 or 55, but a poor site if
it assembled into structures from cluster 49 (Figure S5D). Treat-
ment of CCH-9-expressing cells with BC led to a 2-fold increase
in ReAsH fluorescence relative to untreated cells (Figures 5D and
S5G). The increase in ReAsH fluorescence observed in this case
effectively rules out the formation of cluster-49 structures in the
presence of BC, but fails to differentiate between the structures
represented by clusters 12 and 55. Thus, we turned to CCH-5,
which would generate a poor ReAsH binding site if the JM-A is
assembled as prescribed by cluster 12, and an ambiguous site
if assembled as prescribed by cluster 55. Treatment of CCH-5-
expressing cells with BC did not result in a significant increase
in ReAsH fluorescence relative to untreated cells (Figures 5D
and S5G). The fact that CCH-5 does not bind ReAsH upon acti-
vation by BC supports the model represented by cluster 12,
which was predicted to display a poor site for ReAsH binding
with the CCH-5 Cys-Cys motifs (Figure S5D). Together, these re-
sults suggest that activation by BC does not simply increase the
flexibility of the JM-A, but rather leads to the formation of a
discrete helical interface that is represented by the structures
in cluster 12.
DISCUSSION
The TGF-a-type antiparallel coiled coil induced in the JM-A by
TGF-a, AR, EPI, and ER and identified by tetracysteine bipartite
display differs in unmistakable ways from the EGF-type structure
identified previously (Figure 5E) (Jura et al., 2009). With TGF-a
bound, the two JM-A helices are rotated by 150 in opposite di-780 Chemistry & Biology 22, 776–784, June 18, 2015 ª2015 Elsevier Ltd All rights reservedrections about the helical axis relative to
the EGF-bound structure. This disrotatory
motion flips the coiled coil inside-out,
effectively interchanging those residues
at the coiled-coil interface for those on
the outside surface. In contrast to the
coiled-coil interface induced by EGF,
which is stabilized by leucines at the a
and d positions and complementary saltbridge interactions at positions e and g, the TGF-a-type interface
contains polar residues at these positions and leucine residues
on the coiled-coil exterior (Figures S1B and S1C). In particular,
our data point to a TGF-a-induced antiparallel structure stabi-
lized by salt bridge/polar interactions between R657 (at position
a) and R656 (at position g) on one helix and E0661 (at position e0)
and Q0660 (at position d0), respectively, on the other. The JM-A
conformation induced when EGFR is activated by BC, repre-
sented by cluster 12, is intermediate between the EGF- and
TGF-a-activated structures, possessing both a hydrophobic
and polar interface. Specifically, the BC-type coiled coil utilizes
a leucine interface at the d and g (and d0 and g0) positions while
using complementary polar interactions between R656 and
Q660 at the a and e (and a0 and e0) positions. It has been hypoth-
esized that the residues on the outside of the short coiled coil
could interact with the membrane (Endres et al., 2013; Jura
et al., 2009). While we chose to examine the unbiased interaction
between the two JM-A helices, we did observe positively
charged residues on the outside of the EGF-activated (R653
and R657), TGF-a-activated (K652 and R662), and BC-activated
(R651, R657, and R662) conformations, further validating these
models in the context of the whole, membrane-embedded
receptor.
We note that while coiled-coil interfaces in natural proteins are
often stabilized by hydrophobic interactions, there has been a
more recent appreciation of stabilizing polar salt bridges (Meier
et al., 2010). In fact, among dimeric, antiparallel polar coiled-
coil interfaces, themost common interfacial motif consists of po-
lar residues at the core positions gd0, dg0, ae0, and ea0: precisely
the arrangement seen in TGF-a-cluster 1 (Meier et al., 2010).
Coiled coils stabilized by polar interactions have been observed
in proteins whose function demands multiple interhelical inter-
faces (Croasdale et al., 2011) and short sequences that facilitate
dimerization (Burkhard et al., 2000), two characteristics shared
with the EGFR JM. Thus, the JM-A sequence, which possesses
residues for both a hydrophobic helical interface and multiple
salt bridging residues, uniquely allows the receptor to adoptmul-
tiple, distinct conformations.
In this work, we correlate previously identified ligand-dictated,
downstream signaling differences to induced structure within the
JM: a more down-regulated, shorter signaling pulse upon EGF
and HB-EGF activation is associated with formation of a JM-A
conformation in which leucine residues mediate the interhelical
Figure 5. JM-A Conformation Correlates
with Effects on Downstream Signaling
(A) Quantified fold increase in expression-cor-
rected ReAsH fluorescence over background of
cells expressing CCH-1 or CCH-10 and treated
with either EGF, TGF-a, BC, HB-EGF (1 ng/ml)
or AR, ER, or EPI (2 mg/ml). For TIRF micro-
scopy images and western blots showing the
activity of CCH-1 and CCH-10 upon stimulation
with each growth factor, see also Figures S5A
and S5B.
(B) Helical wheel diagrams illustrating the in-
terfaces of three antiparallel structures potentially
adopted in the BC-activated JM-A region of
EGFR.
(C) CCH-5 and CCH-9 primary sequences.
(D) Quantified fold increase in expression-cor-
rected ReAsH fluorescence over background of
cells expressing CCH-5 or CCH-9 and treated with
or without EGF, TGF-a, or BC (1 ng/ml). For helical
wheel diagrams showing the relative orientation of
Cys-Cys motifs in EGFR variants when assembled
into the antiparallel coiled coils defined by clusters
12, 55, and 49, see Figures S5C and S5D. For TIRF
microscopy images and western blots showing the
activity of CCH-5 and CCH-9 upon stimulation with
EGF, TGF-a, and BC, see Figures S5F and S5G.
(E) EGFR stimulates three ligand-stimulated JM-A
conformations. Activation by EGF and HB-EGF
is best represented by cluster-5 structures
with a hydrophobic interface while activation by
TGF-a, AR, ER, and EPI are best represented by
cluster-1 structures with a polar interface. BC-
activated EGFR likely adopts an intermediary conformation represented by cluster 12. All structures show the side chains of L655, L658, and L659 explicitly.
Error bars represent SE. **p < 0.01, ***p < 0.001, ****p < 0.0001 from one-way ANOVA with Bonferroni post-test (see also Figure S5).interface. On the other hand, the more recycled receptor with a
sustained signaling pulse that results from TGF-a, AR, ER, and
EPI activation is associated with formation of an inside-out
JM-A conformation in which polar interactions line the interface
and hydrophobic leucine residues are on the outside. The corre-
lation breaks down for a single outlier, BC, whose activated
JM-A conformation is intermediary with only a 50 disrotatory
motion separating the two. It is possible that these two struc-
tures are close enough to induce similar signaling downstream
of the receptor, or perhaps the difference in helical structure
has an impact on signaling outcomes that are presently not
appreciated (Saito et al., 2004). It has been posited that receptor
flexibility is an intrinsic property of receptors capable of engaging
multiple ligands and signaling proteins (Nygaard et al., 2013),
potentially explaining why this molecular mechanism has been
difficult to study in many receptor tyrosine kinases.
The ligand-dependent differences in JM structure uncovered
in this work imply analogous ligand-dependent differences in
the conformation of the bound ECD that are propagated to the
JM through domain IV and the transmembrane domain. We
have previously shown that differences in the binding modes of
EGF and TGF-a must lead to differential positioning of domain
IV in the ECD (Scheck et al., 2012). In addition, molecular dy-
namics simulations have revealed subtle differences in the
ligand-bound conformations of the ECD (Sanders et al., 2013),
and domain II has recently been identified as a potential mediator
of subtle differences in ligand binding and specific receptorChemistry & Biology 22,states (Bessman et al., 2014). Furthermore, mutations in the
JM-A region alter the energetics of ligand binding to the ECD
(Macdonald-Obermann and Pike, 2009), and there is clear evi-
dence that the active conformation of the EGFR transmembrane
is flexible and capable of adopting multiple conformations (En-
dres et al., 2013), like other single-pass transmembrane domains
(Dominguez et al., 2014). Taken together, these observations
support a model in which different ligand-dependent JM-A con-
formations result from three distinct ligand-bound ECD confor-
mations that are transmitted faithfully through the membrane-
sequestered transmembrane helical dimer.
Our results support a recent theory that EGFR displays ligand
functional selectivity (Wilson et al., 2009), or biased signaling,
such that activation by a ligand stimulates the population of
distinct conformations that singularly dictate downstream
signaling differences (Kahsai et al., 2011; Liu et al., 2012). While
many RTKs respond tomultiple ligands and effect ligand-depen-
dent signaling, a molecular link between the structure of the
ligand-bound receptor and its distinct ligand-mediated cellular
outcome has not been firmly established (Thomas et al., 2011).
Here, we report direct evidence that different extracellular
EGFR ligands induce distinct conformations of the intracellular
JM-A region of the receptor. There are multiple mechanisms
by which different JM conformations could dictate downstream
signaling. First, it is possible that proteins known to bind to the
JM-A region and induce various signaling pathways, such as
calmodulin (Martin-Nieto and Villalobo, 1998), Nck adaptor776–784, June 18, 2015 ª2015 Elsevier Ltd All rights reserved 781
protein (Hake et al., 2008), GaS (Poppleton et al., 2000), PKC
(Hunter et al., 1984), and p38MAPK (Takishima et al., 1988), are
preferentially recruited by one specific JM conformation. It is
also possible that differential display of nuclear (Lin et al.,
2001) and basolateral (Ryan et al., 2010) sorting motifs in the
JM-A could differentially traffic the receptor. Lastly, specific
JM-A conformations could directly bind to the surface of the
asymmetric kinase dimer, leading to further propagation of sub-
tle conformational changes through the kinase domains and dif-
ferential C-terminal tail phosphorylation (Wilson et al., 2009). It
may be possible to generate EGFR mutants that assemble into
one coiled coil or the other, irrespective of growth factor treat-
ment. These mutants will provide confirmation that both struc-
tures are capable of autophosphorylation and evaluate the role
of each in downstream events. Our observation of distinct
ligand-dependent JM-A conformations in surface receptors
does not support the current belief that ligand-dependent down-
stream signaling differences result from differences in the pH-
dependent ligand occupancy of endocytosed receptors, as our
experiments were conducted with endocytosis inhibited (Ebner
and Derynck, 1991; French et al., 1995). Interestingly, the validity
of this theory has also been questioned by others (Fortian and
Sorkin, 2014), and it is possible that ligand-dependent effects
on cell state arise from a more complicated mechanism. Further
experiments are necessary to distinguish between these various
theories.
SIGNIFICANCE
Many common cancers are caused by aberrant activation of
the EGFR. How EGFR is activated by growth factors to direct
different signaling outcomes is not understood. While it was
originally proposed that growth factor-dependent signaling
differences arise from differential occupancy of the receptor
during endocytosis, here we show that EGFR decodes
growth factor identity by adopting discrete conformations
in each ligand-activated state. We use a pro-fluorescent
small molecule probe in combination with computational
modeling to detect and characterize three distinct ligand-
activated conformations. We further discover that these
conformations track with the downstream signaling profiles
for each ligand, providing evidence for growth factor func-
tional selectivity by EGFR.
EXPERIMENTAL PROCEDURES
RosettaDock Modeling of JM Interfaces
RosettaDock (Rosetta 3.4) (Gray et al., 2003) was used for all docking calcula-
tions. We used the JM model described by Jura et al. (2009) as the input, with
each helix of the short coiled-coiled-like structure treated as one of the two
docking partners. This structure was run first through the docking prepack al-
gorithm (Rosetta 3.4) to optimize initial side-chain positions. The initial, relative
positions of the two helices were both randomized. Both the outer and inner
stages of the low-resolution step of the docking procedure were cycled
20 times and all possible side-chain rotamers were incorporated into the algo-
rithm for the high-resolution step. 25,000 output structures were created and
sorted based on overall RosettaDock energy score. The 1,000 top-scoring
structures were then processed by the cluster application (Rosetta 3.4)
whereby the total number of clusters was limited to 100 and a 1.4-A˚ RMSD cut-
off was used. The resulting clusters were ranked on the basis of their Rosetta
energy scores.782 Chemistry & Biology 22, 776–784, June 18, 2015 ª2015 ElsevierReAsH Labeling Assay
ReAsH labelingwasaccomplished asdescribedpreviously (Scheck et al., 2012)
with the following changes: 63,000 cells were used to seed the experiment,
Disperse Blue was omitted from the ReAsH labeling step, a 1:2,000 dilution of
Alexa Fluor 488 Goat Antimouse IgG, IgA, IgM (H + L) Antibody (2 mg/ml) was
used as the secondary antibody in the last step, and nuclei were labeled with
1.62 mM Hoechst 33342 for 5 min at 37C. Additionally, EGF, TGF-a, HB-EGF,
and BC were used at a concentration of 100 ng/ml while ligands with a weaker
affinity including AR, ER, and EPI were used at concentration of 2 mg/ml.
TIRF Microscopy
TIRF microscopy was conducted on a Leica microsystems AM TIRF MC
DMI6000B fitted with an EM-CCD camera (Hamamatsu) with either the
HCX PL APO 633/1.47 or 1003/1.47 oil corrective objectives. A 12-V 100-W
halogen lamp was used for fluorescence application. In TIRF mode, EGFR
labeled with Alexa Fluor 488 was excited using the 488-nm laser and ReAsH
was excited with the 561-nm laser, while signals were processed in the QAD
TIRF filtercube. Hoechst-stained nuclei were visualized in epifluorescence
mode with the cyan fluorescent protein filtercube. Images were analyzed as
described previously (Scheck et al., 2012).
Western Blot Analysis of EGFR Autophosphorylation
CHO-K1 cells were maintained in Ham’s F-12K (Kaighn’s) medium with 10%
fetal bovine serum at 37C with 5% CO2. 100-mm dishes were seeded with
1.5 3 106 cells for 18 hr, at which point the cells were transfected with either
wild-type or Cys-Cys EGFR variants of EGFR with TransIT-CHO kit according
to the manufacturer’s instructions. After 8 hr, the cells were serum starved for
another 18 hr and then harvested using non-enzymatic cell dissociation solu-
tion and washed with Dulbecco’s PBS, and 500,000 cells were pipetted into
wells of a 96-well plate. To each well was added a 200-ml aliquot of one of
the following reagents, and the incubation continued at 37C for 5 min:
serum-freemedia, 100 ng/ml of EGF, TGF-a, HB-EGF, or BC in serum-freeme-
dia, or 2 mg/ml of AR, ER, or EPI in serum-free media. Cells were then washed
with serum-free media and lysed in 120 ml of 50 mM Tris, 150 mM NaCl, 1 mM
EDTA, 1mMNaF, and 1%TritonX-100 (pH7.5)with protease andphosphatase
inhibitors (1 tablet/10ml) for 1–2hr on ice. Lysatewas then clarified at 14,000 rcf
for 25 min at 4C. For western blot analysis, lysates were run on a 10% poly-
acrylamide SDS-PAGE gel and transferred to polyvinylidene fluoride mem-
branes using an iBlot (Invitrogen). Membranes were blocked with 5% milk in
TBS-T (50 mM Tris, 150 mM NaCl, 0.1% Tween, pH 7.4) for 1–3 hr followed
by an overnight incubation at 4C of either rabbit a-pY1173 or mouse
a-FLAG primary antibodies. Blots were then washed with 5% milk in TBS-T
and incubated with either a-rabbit or a-mouse horseradish peroxidase conju-
gate secondary antibodies for 1 hr at room temperature, then washed with
TBS-T and visualized using Clarity Western ECL reagents.
Statistical Analysis
Comparisons within groups were made using ANOVA. Pairwise comparisons
within groupsweremade using Bonferroni’s post-test after finding a significant
difference using ANOVA. The p values are corrected using Bonferroni’s
method (Shaffer, 1995) so that the family-wise error rate is 0.05.
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